Daniel Scherman

发表

Persistent luminescence in nanophosphors for long term in-vivo bio-imaging

Bruno Viana, S. K. Sharma, Didier Gourier, 2015, Photonics West - Biomedical Optics.

Trap depth optimization to improve optical properties of diopside-based nanophosphors for medical imaging

Bruno Viana, Didier Gourier, Thomas Maldiney, 2012, OPTO.

Growth factor delivery approaches in hydrogels.

Daniel Scherman, Cyrille Richard, Otto-Wilhelm Merten, 2009, Biomacromolecules.

Silicates doped with luminescent ions: useful tools for optical imaging applications

Daniel Scherman, Cyrille Richard, Corinne Chanéac, 2009, BiOS.

The dynamic and urgent path of rare disease and orphan drug research

Daniel Scherman, 2021 .

The in vivo activation of persistent nanophosphors for optical imaging of vascularization, tumours and grafted cells.

Didier Gourier, Thomas Maldiney, Eliott Teston, 2014, Nature materials.

Optimisation of intradermal DNA electrotransfer for immunisation.

Gaëlle Vandermeulen, Véronique Préat, Daniel Scherman, 2007, Journal of controlled release : official journal of the Controlled Release Society.

Synthesis and Evaluation of Amphiphilic Poly(tetrahydrofuran-b-ethylene oxide) Copolymers for DNA Delivery into Skeletal Muscle

Daniel Scherman, D. Scherman, A. Kichler, 2008, Pharmaceutical Research.

Long term in vivo imaging with Cr3+ doped spinel nanoparticles exhibiting persistent luminescence

Didier Gourier, Thomas Maldiney, Daniel Scherman, 2016 .

Development and characterization of new cyclodextrin polymer-based DNA delivery systems.

Daniel Scherman, D. Scherman, A. Kichler, 2008, Bioconjugate chemistry.

Storage of Visible Light for Long-Lasting Phosphorescence in Chromium-Doped Zinc Gallate

Didier Gourier, Thomas Maldiney, Daniel Scherman, 2014 .

Colon tumor growth and antivascular treatment in mice: complementary assessment with MR elastography and diffusion-weighted MR imaging.

Ralph Sinkus, Daniel Scherman, Nathalie Mignet, 2012, Radiology.

Gadolinium‐Doped Persistent Nanophosphors as Versatile Tool for Multimodal In Vivo Imaging

Thomas Maldiney, Daniel Scherman, Cyrille Richard, 2015 .

New generation of plasmid backbones devoid of antibiotic resistance marker for gene therapy trials.

Gaëlle Vandermeulen, Véronique Préat, Daniel Scherman, 2011, Molecular therapy : the journal of the American Society of Gene Therapy.

Controlling electron trap depth to enhance optical properties of persistent luminescence nanoparticles for in vivo imaging.

Didier Gourier, Thomas Maldiney, Daniel Scherman, 2011, Journal of the American Chemical Society.

In vivo plasmid DNA electrotransfer.

Daniel Scherman, D. Scherman, M. Bureau, 2002, Current opinion in biotechnology.

Nanoprobes with near-infrared persistent luminescence for in vivo imaging

Didier Gourier, Daniel Scherman, Johanne Seguin, 2007, Proceedings of the National Academy of Sciences.

In vitro targeting of avidin-expressing glioma cells with biotinylated persistent luminescence nanoparticles.

Seppo Ylä-Herttuala, Thomas Maldiney, Daniel Scherman, 2012, Bioconjugate chemistry.

NLS bioconjugates for targeting therapeutic genes to the nucleus.

Marie Carrière, Pierre Wils, Daniel Scherman, 2003, Advanced drug delivery reviews.

Applications of Plasmid Electrotransfer

Daniel Scherman, D. Scherman, M. Bureau, 2002, Technology in cancer research & treatment.

pH-sensitive PEG lipids containing orthoester linkers: new potential tools for nonviral gene delivery.

Daniel Scherman, Nathalie Mignet, Michel Bessodes, 2004, Journal of controlled release : official journal of the Controlled Release Society.

Noncovalent functionalization of carbon nanotubes with amphiphilic gd3+ chelates: toward powerful t1 and t2 MRI contrast agents.

Daniel Scherman, Cyrille Richard, Michel Bessodes, 2008, Nano letters.

Physicochemical optimisation of plasmid delivery by cationic lipids

Daniel Scherman, Nathalie Mignet, D. Scherman, 2004, The journal of gene medicine.

The regionalization of [3H]dihydrotetrabenazine binding sites in the mouse brain and its relationship to the distribution of monoamines and their metabolites

Daniel Scherman, D. Scherman, J. Henry, 1986, Brain Research.

Effect of core diameter, surface coating, and PEG chain length on the biodistribution of persistent luminescence nanoparticles in mice.

Thomas Maldiney, Daniel Scherman, Cyrille Richard, 2011, ACS nano.

Chemically engineered persistent luminescence nanoprobes for bioimaging

Thomas Maldiney, Eliott Teston, Daniel Scherman, 2016, Theranostics.

Plasmid DNA electrotransfer for intracellular and secreted proteins expression: new methodological developments and applications

Daniel Scherman, D. Scherman, M. Bureau, 2004, The journal of gene medicine.